|
| Study | Type of anastomosis | Type of Lymphadenectomy, number (%) | Mean number of lymph node, mean (SD) | R0 rate, number (%) | Operative time, mean (SD) | Blood loss, mean (SD) | Conversion rate, number (%) | Duodenal leakage, number (%) | Anastomosis leakage |
|
| Dulucq et al. [10] | Roux-en-Y or Billroth II | N/E | Open: 17 (6)
LC: 21.66 (10.56) | Open: 27 (96%)
LC: 24 (100%) | Open: 140.10 (41.32)
LC:147.66 (37.53) | N/E | N/E | Open: 0
LC:1 (4%) | N/E |
|
| Huscher et al. [11] | Roux-en-Y or Billroth II | D1: Open 9 (31%), LC 9 (30%)
D2: Open 20 (69%), LC 21 (70%) | Open: 33.4 (17.4)
LC: 30 (14.9) | N/E | Open: 168 (29)
LC: 196 (21) | Open: 391 (136)
LC: 229 (144) | 0 (0%) | Open: 1 (3.4%)
LC: 0 | Open: 0
LC: 0 |
|
| Pugliese et al. [12] | Roux-en-Y | D2 | Open: 36 (14)
LC: 32 (9) | Open: 99 (100%)
LC: 48 (100%) | Open: 220 (31)
LC: 240 (23) | Open: 394 (125)
LC: 150 (85) | 1 (2%) | Open: 1 (1%)
LC: 2 (4%) | Open: 2 (2%)
LC: 0 (0%) |
|
| Topal et al. [13] | Roux-en-Y | D2 | N/E | Open: 21 (95%)
LC: 37 (97%) | Open: 150 (25)
LC: 187 (60) | Open: 175 (337.5)
LC: 20 (98.75) | N/E | N/E | Open: 0
LC: 2 (5%) |
|
| Sarela et al. [14] | Roux-en-Y | D2 | Open: 38.75 (26.17)
LC: 25 (15.15) | Open: 7 (63%)
LC: 13 (72%) | Open: 300 (54.7)
LC: 400 (104.2) | N/E | 5 (28%) | Open: 1 (9%)
LC: 3 (17%) | N/E |
|
| Chouillard et al. [15] | Roux-en-Y | D2 | Open: 22 (34.5)
LC: 19 (10.75) | Open: 73 (92.4%)
LC: 49 (96.1%) | Open: 200 (60)
LC: 260 (37.5) | Open: 372 (208.75)
LC: 150 (205) | 2 (3.9%) | N/E | N/E |
|
| Orsenigo et al. [16] | Roux-en-Y | D2 | Open: 27 (13)
LC: 31 (14) | Open: 239 (89%)
LC: 103 (94%) | Open:230 (101)
LC: 272 (74) | Open: 372 (401)
LC:170 (199) | 17 (15.6%) | Open: 14 (5.2%)
LC: 20 (18.3%) | N/E |
|
| Bouras et al. [17] | Roux-en-Y or Billroth I | D1: Open 51 (54%) LC 233 (90%)
D2: Open 44 (46%)
LC 26 (10%) | Open: 31.43 (14.14)
LC: 26.71 (12.64) | N/E | Open: 252 (122.5)
LC: 304 (105) | Open: 310.2 (555)
LC: 84.9 (198.75) | N/E | N/E | Open: 3 (3%)
LC: 7 (3%) |
|
| Scatizzi et al. [18] | Roux-en-Y | D2 | Open: 37 (16)
LC: 31 (11) | Open: 30 (100%)
LC: 30 (100%) | Open: 180 (49)
LC: 240 (65) | N/E | 2 (6.6%) | N/E | Open: 0
LC:2 (7%) |
|
| Sica et al. [19] | Roux-en-Y or Billroth II | D1: Open 2 (8%), LC 2(9%)
D2: Open 23 (92%), LC 20 (91%) | Open: 30 (9)
LC: 29 (7) | N/E | N/E | N/E | N/E | N/E | Open: 0
LC:0 |
|
| Siani et al. [20] | Roux-en-Y | D2 | Open: 40 (16)
LC: 35 (18) | N/E | Open: 185 (19)
LC: 211 (23) | Open: 495 (190)
LC: 250 (150) | 0 (0%) | N/E | Open: 0
LC:1 (4%) |
|
| Cianchi et al. [21] | Roux-en-Y and billroth II | D1: Open 2 (5%), LC 4 (10%)
D2: Open 39 (95%), LC 37 (10%) | Open: 28.7 (2.3)
LC: 29.4 (1.6) | Open: 40 (97.6%)
LC: 41 (100%) | N/E | Open: 312.4 (42.9)
LC: 118.7 (10.7) | 0 (0%) | Open: 2 (4.9%)
LC: 2 (4.9%) | Open: 2 (4.9%)
LC: 0 |
|
| Mamidanna et al. [22] | N/E | N/E | N/E | N/E | N/E | N/E | N/E | N/E | N/E |
|
| Brenkman et al. [23] | N/E | D2 | Open: 15 (6.5)
LC: 18 (6.33) | Open: 1447 (87%)
LC: 249 (90%) | N/E | N/E | 24 (9%) | N/E | N/E |
|
